Skip to main content

Month: February 2020

Cowen Outsourced Trading Wins 2020 Hedgeweek Annual Global Award

NEW YORK, Feb. 28, 2020 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that its global Outsourced Trading group was recognized as the “Best Outsourced Trading Provider” at the 2020 Hedgeweek Global Awards event. The criteria for the awards were based on an online peer review system in which managers, fund administrators, prime brokers, custodians and advisers were invited to elect “best in class” in a variety of categories.Upon winning the award for the second year in a row, Bobby Croswell, Managing Director, Outsourced Trading, said, “We’re honored to be recognized yet again by Hedgeweek and our peers in the industry as ‘Best Outsourced Trading Provider’. This award validates our continued commitment to providing reliable, secure and innovative service and solutions to support our clients....

Continue reading

Celsion Corporation Prices $4.8 Million Registered Direct Offering

LAWRENCEVILLE, NJ, Feb. 28, 2020 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into securities purchase agreements with institutional investors for the purchase and sale of 4,571,428 shares of the Company’s common stock, par value $0.01 per share, pursuant to a registered direct offering. The Company has also agreed to issue to such investors, in a concurrent private placement, warrants to purchase 2,971,428 shares of the Company’s common stock. The warrants will be exercisable on the six-month anniversary of the issuance date, will expire on the five-year anniversary of the initial exercise date and have an exercise price of $1.15 per share. The gross proceeds of the offering will be approximately $4.8 million before deducting placement agent fees and other estimated...

Continue reading

Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®

Acquisition Expected to be Immediately Accretive to Adjusted EBITDA1Announces US$20 Million Credit Facility with MidCap FinancialTORONTO and CHICAGO and MONTREAL, Feb. 28, 2020 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced that the Company, through its US-based subsidiary, acquired Aptevo BioTherapeutics LLC, a Delaware limited liability company owning the worldwide rights to the commercial hematology asset, IXINITY®, from Aptevo Therapeutics, Inc. (NASDAQ: APVO) (the “Vendor”), a biotechnology company focused on developing oncology, autoimmune and hematology therapeutics (the “Acquisition”). IXINITY® is an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B – a hereditary bleeding disorder characterized...

Continue reading

BWMG’s BLU3 Forms First International Distributor Relationship and Nemo by BLU3 Well Received at the 2020 Miami International Boat Show

Pompano Beach, Florida, Feb. 28, 2020 (GLOBE NEWSWIRE) — Brownie’s Marine Group, Inc. (OTC:BWMG) a leading developer, manufacturer and distributor of modern recreational diving products and onboard compressed air solutions is pleased to announce that it has recently formed a relationship with its first international distributor, Metallsoker AS, for the Nemo product by BLU3. Metallsoker AS, which is headquartered in Holmestrand, Norway, will have exclusive rights to sell into Norway, and surrounding territories will be considered as the partnership grows and more sales accumulate.“We are excited to partner with Metallsoker AS as our first international sales partner. They have a fantastic reputation in the diving and metal detecting community and significant influence in their home markets.” said Robert Carmichael, Chairman &...

Continue reading

Corline Biomedical AB väljer Redeye AB som Certified Adviser

Corline Biomedical AB (”Corline”) har beslutat anlita Redeye AB som Certified Adviser från och med 1 juni 2020.Redeye AB är en specialiserad rådgivningsfirma inriktad på tillväxtbolag inom Life Science-sektorn i Norden och tillhandahåller en stor mängd tjänster inom detta segment, bland annat verkar Redeye som Certified Adviser på First North Growth Market. Det är i denna egenskap Corline beslutat att anlita Redeyes tjänster.Corlines nuvarande Certified Adviser, Svensk Kapitalmarknadsgranskning AB, kommer att verka i denna roll fram till den 31 maj 2020.För mer information om Corline, vänligen kontaktaHenrik Nittmar, VDTelefon: 018-71 30 90E-post: henrik.nittmar@corline.seCertified AdviserSvensk Kapitalmarknadsgranskning ABTelefon: +46 (0)70 755 95 51E-post: ca@skmg.seCorline Biomedical AB arbetar med den kroppsegna substansen heparin...

Continue reading

Arrive Logistics Joins DAT Pilot Program for New Truckload Rate-Prediction Tools

PORTLAND, Ore., Feb. 28, 2020 (GLOBE NEWSWIRE) — DAT Solutions today announced that Arrive Logistics, one of the fastest-growing next-generation freight brokers in the country, has joined a pilot program to evaluate DAT’s latest truckload rate forecasting tools: DAT Market Conditions Index (MCI), a powerful indicator of truckload freight supply and demand, and new rate-prediction technology that leverages DAT RateView, the industry’s most accurate and complete source of spot and contract rate information.“Our growth is predicated on providing our team with technology and data that drive efficiency and customer service,” said David Spencer, Arrive Logistics Director of Business Intelligence. “We are always looking to the future to understand what our partners need and are excited to be among the first to begin incorporating this...

Continue reading

Heeros Oyj: KUTSU HEEROS OYJ:N VARSINAISEEN YHTIÖKOKOUKSEEN

KUTSU HEEROS OYJ:N VARSINAISEEN YHTIÖKOKOUKSEENHeeros Oyj:n osakkeenomistajat kutsutaan varsinaiseen yhtiökokoukseen, joka pidetään 24.3.2020 kello 14.00 alkaen kokoustila Telefunkeniin, Pasilan Visioon, osoitteessa Televisiokatu 4, 00240 Helsinki. Kokoukseen ilmoittautuneiden vastaanottaminen ja kokousta edeltävä kahvitarjoilu alkavat klo 13.30.A. Varsinaisessa yhtiökokouksessa käsiteltävät asiatKokouksessa käsitellään seuraavat asiat:1.               Kokouksen avaaminen2.               Kokouksen järjestäytyminen3.               Pöytäkirjantarkastajien ja ääntenlaskijoiden valitseminen4.               Kokouksen laillisuuden toteaminen5.               Läsnä olevien toteaminen ja ääniluettelon vahvistaminen6.               Vuoden 2019 tilinpäätöksen ja tilitarkastuskertomuksen esittäminenToimitusjohtajan katsaus.7.               Tilinpäätöksen...

Continue reading

Notice convening the Annual General Meeting 2020 in A.P. Møller – Mærsk A/S

We hereby convene the Annual General Meeting of A.P. Møller – Mærsk A/S on Monday 23 March 2020 at 10.00 a.m. at The Opera House, Ekvipagemestervej 10, DK-1438 Copenhagen K.Contact person: Executive Vice President, Lars-Erik Brenøe, tel.: +45 33 63 36 07AttachmentsNotice convening the Annual General MeetingBoard members for electionAppendix 1 – Remuneration Policy

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.